Prellis Biologics is making human anti-SARS-CoV2 antibodies for use against COVID-19 using bioprinted, human mini lymph nodes. In 2017, the printed lymph nodes produced human antibodies for passive immunity against Zika virus. Now, Prellis is doing the same for the…